Curonix
Focus: Curonix develops minimally invasive, wireless neurostimulation systems for chronic pain and neurological indications. The company operates as a medical device innovator with a portfolio spanning spinal cord stimulation, peripheral nerve stimulation, and craniofacial applications.
Profile data last refreshed 4d ago · AI intelligence enriched 2w ago
Open Jobs
0
About Curonix
AI assessmentNot HiringNo open roles listed right now. Follow Curonix to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Freedom SCS System
Stable
Growth
Spinal cord stimulation system for chronic back pain and failed back surgery syndrome; multiple clinical programs underway but no published commercial metrics.
StimRelieve Halo System
Help build intelligence for Curonix
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.